Pilin Wang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer survivorship and care
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 6
- HER2/EGFR in Cancer Research 4
- Peptidase Inhibition and Analysis 3
- CAR-T cell therapy research 3
- Co-authors
- Ting Xu (7 shared papers)Hudie Wei (2 shared papers)Aiwu Zhou (2 shared papers)Haiyan Cai (2 shared papers)Dan Li (2 shared papers)Xiaohua Zhu (2 shared papers)Sijuan Zou (2 shared papers)Siyuan Cheng (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Molecular Pharmaceutics (2 papers)Cancer Research (1 paper)Cell Discovery (1 paper)Marine Biotechnology (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Pilin Wang
30 papers receiving 616 citations
Peers
Comparison fields: 5 of 80
- Oncology 335
- Radiology, Nuclear Medicine and Imaging 214
- Immunology 164
- Molecular Biology 196
- Cancer Research 38
Countries citing papers authored by Pilin Wang
This map shows the geographic impact of Pilin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilin Wang more than expected).
Fields of papers citing papers by Pilin Wang
This network shows the impact of papers produced by Pilin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilin Wang. The network helps show where Pilin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Pilin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 167 | |
| 2 | 2018 | 98 | |
| 3 | 2013 | 60 | |
| 4 | 2017 | 55 | |
| 5 | 2009 | 47 | |
| 6 | 2019 | 28 | |
| 7 | 2009 | 23 | |
| 8 | 2015 | 20 | |
| 9 | 2019 | 18 | |
| 10 | 2012 | 18 | |
| 11 | 2021 | 11 | |
| 12 | ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro. | 2016 | 9 |
| 13 | 2019 | 9 | |
| 14 | 2020 | 8 | |
| 15 | Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor. | 2014 | 8 |
| 16 | 2005 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2011 | 5 | |
| 19 | 2009 | 5 | |
| 20 | 2013 | 5 |
About Pilin Wang
Pilin Wang is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 632 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), HER2/EGFR in Cancer Research (4 papers), Peptidase Inhibition and Analysis (3 papers), CAR-T cell therapy research (3 papers), Breast Lesions and Carcinomas (3 papers), Alzheimer's disease research and treatments (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Oncology (335 citations), Radiology, Nuclear Medicine and Imaging (214 citations), Immunology (164 citations), Molecular Biology (196 citations) and Cancer Research (38 citations). Pilin Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Ting Xu, Hudie Wei, Aiwu Zhou, Haiyan Cai, Dan Li, Xiaohua Zhu, Sijuan Zou, Siyuan Cheng, June Liu and Yali Su. Their work appears in journals such as Journal of Clinical Oncology, Molecular Pharmaceutics, Cancer Research, Cell Discovery and Marine Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.